PolyPhotonix

PolyPhotonix For more information please go to the company website www.polyphotonix.com or the product website ww

PolyPhotonix is pioneering the early adoption of organic light. Working with designers and key customers, it is creating new products and supporting the design process right through to manufacture based at the National Printable Electronics Centre. We are a bio-photonic research and development company that designs, develops and manufactures non-invasive photonic based medical devices for retinal

diseases. Using state of the art in-house facilities in partnership with the Centre for Process Innovation, we research the application of light-based therapies.

16/01/2026

We're happy to be featured on page 12 of the DRWF Diabetes Winter 2026 Newsletter! DRWF funded the early research that led to Noctura 400 development and we appreciate the importance of funding organisations and charities such as DRWF. Research brings new and innovative products to life, but the journey is challenging and funding is vital to get them to market 💙💙💙

PS - why not join DRWF's Wellness Network? As well as funding research, they also provide amazing support to people with diabetes 💙

Lovely to see OutsideClinic advocating our great product Noctura 400!
15/03/2024

Lovely to see OutsideClinic advocating our great product Noctura 400!

🌙✨ Transform your sleep into a healing journey with PolyPhotonix's innovative Noctura 400 eye masks! Designed to tackle and prevent diabetic retinopathy, these masks offer a non-invasive, comfortable solution to protect your vision, all while you catch your Z’s.

The magic lies in the specific wavelength of light that Noctura 400 emits, illuminating your retina to prevent new leaky blood vessels from forming. Ideal for early-stage intervention or alongside standard treatments, it's a game-changer in eye care. Remember, always chat with your Ophthalmologist before adjusting your treatment.

Sleep peacefully knowing you're taking steps to protect your eyesight with Noctura 400. 💤👁️

For more information about Diabetic retinopathy or Noctura 400 masks click below 👇
https://loom.ly/olXUzaw

21/12/2023

This Mediaplanet campaign was distributed with the Guardian newspaper and launched on www.healthawareness.co.uk on 19-December 2023.

We're recruiting! Work with us and our flagship product Noctura 400  as we enter a new phase of exciting development! We...
16/02/2023

We're recruiting! Work with us and our flagship product Noctura 400 as we enter a new phase of exciting development! We're looking for a Clinical Services Advisor to help support our valued customers.

Apply online for Clinical Services Advisor jobs in TS21 3FF, Sedgefield, County Durham at CV-Library.co.uk

It's  , and we want to highlight  , a serious consequence of diabetes that 80% of diabetics will develop in their lifeti...
17/06/2022

It's , and we want to highlight , a serious consequence of diabetes that 80% of diabetics will develop in their lifetime. Listen to a top ophthalmologist talk about the condition and treatment options available.

Diabetic retinopathy is a common diabetic eye disease caused by changes in the retinal cells. Mr Ulrich Meyer-Bothling, a renowned consultant ophthalmic surg...

It was a great pleasure to be featured on BBC Radio Tees this week, with DJ's Neil Green and  Oakden. They were excited ...
14/02/2022

It was a great pleasure to be featured on BBC Radio Tees this week, with DJ's Neil Green and Oakden. They were excited to hear about the great progress Noctura 400 is making locally within the UK and around the world!





Noctura 400 has been featured on local radio station BBC Tees.

Look out for PolyPhotonix on The Ophthalmologist Innovators 2021 list, a grand showcase of the year’s most advanced solu...
26/01/2022

Look out for PolyPhotonix on The Ophthalmologist Innovators 2021 list, a grand showcase of the year’s most advanced solutions in ophthalmology - it features our very own Noctura 400! We're thrilled!

As one of the most inventive fields in medicine, ophthalmology is often at the forefront of cutting-edge technologies and treatments. Here, some of the leading innovators from the ophthalmic space present their latest offerings: from imaging and diagnostics, to refractive surgery, and glaucoma care

Read all about Noctura 400 in The Ophthalmologist this month! Noctura 400 is a proven, effective home treatment for Diab...
06/09/2021

Read all about Noctura 400 in The Ophthalmologist this month! Noctura 400 is a proven, effective home treatment for Diabetic Retinopathy. A CE marked medical device, Noctura 400 costs less than current treatments, and vulnerable patients are supported throughout their treatment at home.



Sharing results from a real-world single center study of patients with diabetic macular oedema (DMO) who wore a home-use sleep mask (Noctura 400) for 12 months

It's great to hear more about Noctura 400 benefiting patients across Europe! Noctura 400 for   is featured on Pancreas 4...
28/07/2021

It's great to hear more about Noctura 400 benefiting patients across Europe! Noctura 400 for is featured on Pancreas 404, an Italian Instagram initiative aiming to raise awareness of in young adults.

Noctura 400 has been mentioned on the Italian 'Pancreas 404', an Instagram initiative which aims to promote awareness of diabetes among young adults.

Hot off the press! Consultant Ophthalmologist Mr Ulrich Meyer-Bothling, of Ashford and St. Peter's Hospitals NHS Foundat...
18/06/2021

Hot off the press! Consultant Ophthalmologist Mr Ulrich Meyer-Bothling, of Ashford and St. Peter's Hospitals NHS Foundation Trust, has published great results from using Noctura 400 on patients in his NHS clinic during the pandemic. 98% of eyes improved or stabilised over the 13 month study. Noctura 400 is an effective treatment for diabetic eye disease, available at a fraction of the cost of traditional, more invasive treatment.

A “Real-World” single-centre observational study was carried out to analyse the effects of enhanced patient interaction with the use of the Noctura 400 sleep mask on a group of 26 diabetics displaying diabetic retinopathy (DR) and diabetic macular oedema (DMO), of which 24 completed th...

01/04/2021

Address

Sedgefield
TS213FG

Opening Hours

Monday 9am - 5:30pm
Tuesday 9am - 5:30pm
Wednesday 9am - 5:30pm
Thursday 9am - 5:30pm
Friday 9am - 5pm

Telephone

+441740669139

Alerts

Be the first to know and let us send you an email when PolyPhotonix posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to PolyPhotonix:

Share